Toward less futile surgery in non-small cell lung cancer? A randomized clinical trial to evaluate the cost-effectiveness of positron emission tomography

Controlled Clinical Trials

Volumn 22, Issue 1, 2001, Pages 89-98

  Van Tinteren, Harm ^a   Hoekstra, Otto S ^b   Smit, Egbert F ^b   Verboom, Paul ^c   Boers, Maarten ^b  

^a Integraal Kankercentrum Amsterdam   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Cost effectiveness; Diagnostic imaging; Non small cell lung cancer; Positron emission tomography

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HUMAN; INFORMATION PROCESSING; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MULTICENTER STUDY; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MEDICAL FUTILITY; MIDDLE AGED; SURVIVAL RATE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035152902     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(00)00119-7     Document Type: Article

References (37)

1. Consensus bijeenkomst diagnostiek longcarcinoom
2. Pretreatment minimal staging for non-small cell lung cancer: An updated consensus report
3. Non-small-cell lung cancer practice guidelines
4. Pretreatment evaluation of non-small-cell lung cancer
5. Surgeons' assessment of symptoms suggesting extrathoracic metastases in patients with lung cancer. Canadian Lung Oncology Group
6. Imaging strategies in the staging of lung cancer
7. Management of lung cancer in South East Scotland
8. Staging non-small cell lung cancer patients in two Dutch hospitals
9. CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the Radiologic Diagnostic Oncology Group
10. The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer
11. Investigation for mediastinal disease in patients with apparently operable lung cancer
12. Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s - Meta-analytc comparison of PET and CT
13. Biases in the assessment of diagnostic tests
14. Evaluating the clinical efficacy of diagnostic imaging procedures
15. Use of methodological standards in diagnostic research. Getting better but still not good
16. The identification of bias in studies of the diagnostic performance of imaging modalities
17. Positron Emission Tomography. Descriptive Analysis of Experience with PET in VA
18. Evaluating and comparing imaging techniques: A review and classification of study designs
19. Whole-body 18F-fluorodeoxyglucose positron emission tomography in pre-operative evaluation of lung cancer
20. Outcomes research and cost-effectiveness analysis in radiology
21. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small cell lung carcinoma
22. Cost-effectiveness of FDG-PET for staging non-small cell lung cancer
23. FDG-PET scan in potentially operable non-small cell lung cancer: Do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases?
24. Lymph node mapping and curability at various levels of metastasis in resected lung cancer
25. An overview of cost-effective radiology
26. Evidence-based diagnostic radiology
27. Methodologic issues in comparing imaging methods
28. The poor quality of early evaluations of magnetic resonance imaging
29. Measuring the effects of imaging: An evaluative framework
30. Lung Cancer
31. Linking health technology assessment to practice
32. Outcomes research and cost-effectiveness analysis for diagnostic imaging
33. When and how to assess fast-changing technologies: A comparative study of medical applications of four generic technologies
34. Streptomycin treatment of pulmonary tuberculosis